Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors.
Shah, M Lorigan, Paul C O’Brien, M Fossella, F Moore, K Bhatia, S Kirby, M Woll, P
Shah, M
Lorigan, Paul C
O’Brien, M
Fossella, F
Moore, K
Bhatia, S
Kirby, M
Woll, P
Citations
Altmetric:
Abstract
Description
Date
2016-03-09
Publisher
Collections
Keywords
Type
Article
Citation
Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors 2016 Investigational New Drugs